- Page 1 and 2: MICROPROPAGATION AND MEDICINAL PROP
- Page 3 and 4: 2.1.4 Stage II: Proliferation or mu
- Page 5 and 6: Chapter 5 Pharmacological and phyto
- Page 7 and 8: STUDENT DECLARATION Micropropagatio
- Page 9 and 10: FACULTY OF SCIENCE & AGRICULTURE DE
- Page 11 and 12: AMOO, S.O., FINNIE, J.F. and VAN ST
- Page 13 and 14: LIST OF FIGURES Chapter 1 Figure 1.
- Page 15 and 16: Figure 5.2: Anti-inflammatory activ
- Page 17 and 18: LIST OF TABLES Chapter 2 Table 2.1:
- Page 19 and 20: LIST OF ABBREVIATIONS [3G]BA 6-Benz
- Page 21 and 22: PE Petroleum ether PEPC Phosphoenol
- Page 23 and 24: status. Being a dwarf species, very
- Page 25 and 26: activities shown by H. hystrix extr
- Page 27 and 28: During this same period, these auth
- Page 29 and 30: dark pink with magenta streaks on t
- Page 31 and 32: traditional medicine (muthi) among
- Page 33 and 34: 1.5 Aims and objectives Endemic and
- Page 35 and 36: 2.1 Micropropagation 2.1.1 Introduc
- Page 37 and 38: their constituent cells (MURASHIGE,
- Page 39 and 40: media are sterile, the explants mai
- Page 41 and 42: plants is higher (MURASHIGE, 1978)
- Page 43 and 44: adventitious roots are produced wit
- Page 45 and 46: DEBERGH and MAENE (1981) therefore
- Page 47: cytokinins as well as these major e
- Page 51 and 52: 6-Benzyladenine (BA) 6-Furfurylamin
- Page 53 and 54: STADEN and DREWES, 1992), the relat
- Page 55 and 56: growth and development throughout t
- Page 57 and 58: HASEGAWA et al (1973) reported a co
- Page 59 and 60: Table 2.1 continued Plant species E
- Page 61 and 62: 2.2 Pharmacological and phytochemic
- Page 63 and 64: filamentous fungi (such as Fusarium
- Page 65 and 66: PGI2, PGF2α, are known to sensitiz
- Page 67 and 68: Many researchers have reported anti
- Page 69 and 70: inclusion of antioxidant and free r
- Page 71 and 72: activity of gallotannins from Mangi
- Page 73 and 74: 3.1 Introduction Chapter 3 In vitro
- Page 75 and 76: with 30 g l -1 sucrose, 0.1 g l -1
- Page 77 and 78: andomised and maintained in a growt
- Page 79 and 80: 3.3.1 Explant decontamination Figur
- Page 81 and 82: Adventitious shoots per explant (n)
- Page 83 and 84: 3.3.3 Effects of types and concentr
- Page 85 and 86: Table 3.1: Effects of types and con
- Page 87 and 88: 3.3.4 Effects of photoperiod on sho
- Page 89 and 90: to be a slow release reservoir of a
- Page 91 and 92: Percentage survival 70 60 50 40 30
- Page 93 and 94: exponential population growth rates
- Page 95 and 96: Cultures were incubated under the s
- Page 97 and 98: loosely closed screw cap jars (300
- Page 99 and 100:
Frequency of decontamination (%) 60
- Page 101 and 102:
Table 4.2: Frequencies of shoot, ro
- Page 103 and 104:
SALISBURY and ROSS (1992), a temper
- Page 105 and 106:
Table 4.5: Effects of temperature a
- Page 107 and 108:
photoperiod could therefore be due
- Page 109 and 110:
Titratable acidity (µM H + g -1 FW
- Page 111 and 112:
Figure 4.4: Huernia hystrix adventi
- Page 113 and 114:
strength MS medium with or without
- Page 115 and 116:
Chapter 5 Pharmacological and phyto
- Page 117 and 118:
Garden, Pietermaritzburg, South Afr
- Page 119 and 120:
2004) respectively, were also deter
- Page 121 and 122:
each of the plant extracts, the bla
- Page 123 and 124:
ORR =
- Page 125 and 126:
5.2.3.5 Gallotannin content The rho
- Page 127 and 128:
Barleria species, the EtOH extracts
- Page 129 and 130:
Table 5.2: Yield (% w/w) of extract
- Page 131 and 132:
Table 5.4: Antibacterial activity (
- Page 133 and 134:
Table 5.5: Antifungal activity of c
- Page 135 and 136:
5.3.2.3 Anti-inflammatory activity
- Page 137 and 138:
Prostaglandin synthesis inhibition
- Page 139 and 140:
The AChE inhibitory activity of ext
- Page 141 and 142:
(A) DPPH Scavenging activity (%) (B
- Page 143 and 144:
Table 5.8: DPPH radical scavenging
- Page 145 and 146:
Absorbance 630 nm 2.2 2.0 1.8 1.6 1
- Page 147 and 148:
(ORHAN et al., 2009; ABDEL-HAMEED,
- Page 149 and 150:
5.3.3 Phytochemical evaluation 5.3.
- Page 151 and 152:
5.3.3.2 Total iridoid content Figur
- Page 153 and 154:
5.3.3.3 Flavonoid content The flavo
- Page 155 and 156:
5.3.3.4 Gallotannin content The roo
- Page 157 and 158:
5.3.3.5 Condensed tannin (proanthoc
- Page 159 and 160:
Chapter 6 General conclusions An ef
- Page 161 and 162:
evaluating their safety may be nece
- Page 163 and 164:
ANAND, Y. and BANSAL, Y.K. 1998. Pl
- Page 165 and 166:
BASKARAN, P., VELAYUTHAM, P. and JA
- Page 167 and 168:
CHENG, S.H. and EDWARDS, G.E. 1991.
- Page 169 and 170:
DE KLERK, G.J., BRUGGE, J.T. and MA
- Page 171 and 172:
ETKIN, N.L. 1998. Indigenous patter
- Page 173 and 174:
GIRIDHAR, P., GURURAJ, H.B. and RAV
- Page 175 and 176:
HUANG, D., OU, B. and PRIOR, R.L. 2
- Page 177 and 178:
KIRANMAI, C., ARUNA, V., KARUPPUSAM
- Page 179 and 180:
LITZ, R.E. and CANOVER, R.A. 1981.
- Page 181 and 182:
MARKS, T.R. and SIMPSON, S.E. 1994.
- Page 183 and 184:
NDAWONDE, B.G., ZOBOLO, A.M., DLAMI
- Page 185 and 186:
PAREEK, A. and KOTHARI, S.L. 2003.
- Page 187 and 188:
RAI, M.K., AKHTAR, N. and JAISWAL,
- Page 189 and 190:
threatened plants - progress in the
- Page 191 and 192:
SRIVASTAVA, L.M. 2002. Plant Growth
- Page 193 and 194:
TURNER, S. 2001. Witwatersrand Nati
- Page 195:
WILLIAMSON, E., OKPAKO, D.T. and EV